##fileformat=VCFv4.0
##INFO=<ID=OTHER,Number=.,Type=String, Description = "Other Information From Original File">
##INFO=<ID=SAMPLE,Number=.,Type=String,Description="Sample id">
##INFO=<ID=CDS,Number=.,Type=String,Description="Coding Variants or not">
##INFO=<ID=VA,Number=.,Type=String,Description="Coding Variant Annotation">
##INFO=<ID=HUB,Number=.,Type=String,Description="Network Hubs, PPI (protein protein interaction network), REG (regulatory network), PHOS (phosphorylation network)...">
##INFO=<ID=GNEG,Number=.,Type=String,Description="Gene Under Negative Selection">
##INFO=<ID=GERP,Number=.,Type=String,Description="Gerp Score">
##INFO=<ID=NCENC,Number=.,Type=String,Description="NonCoding ENCODE Annotation">
##INFO=<ID=HOT,Number=.,Type=String,Description="Highly Occupied Target Region">
##INFO=<ID=MOTIFBR,Number=.,Type=String,Description="Motif Breaking">
##INFO=<ID=MOTIFG,Number=.,Type=String,Description="Motif Gain">
##INFO=<ID=SEN,Number=.,Type=String,Description="In Sensitive Region">
##INFO=<ID=USEN,Number=.,Type=String,Description="In Ultra-Sensitive Region">
##INFO=<ID=UCONS,Number=.,Type=String,Description="In Ultra-Conserved Region">
##INFO=<ID=GENE,Number=.,Type=String,Description="Target Gene (For coding - directly affected genes ; For non-coding - promoter, enhancer regulatory module)">
##INFO=<ID=CANG,Number=.,Type=String,Description="Prior Gene Information, e.g.[cancer][TF_regulating_known_cancer_gene][up_regulated][actionable]...";
##INFO=<ID=CDSS,Number=.,Type=String,Description="Coding Score">
##INFO=<ID=NCDS,Number=.,Type=String,Description="NonCoding Score">
##INFO=<ID=RECUR,Number=.,Type=String,Description="Recurrent elements / variants">
##INFO=<ID=DBRECUR,Number=.,Type=String,Description="Recurrence database">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
chr1	236925812	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=5.43;CDS=Yes;VA=1:ACTN2:ENSG00000077522.8:+:prematureStop:3/3:ACTN2-001:ENST00000366578.4:2685_2578_860_Q->*:ACTN2-201:ENST00000542672.1:2685_2578_860_Q->*:ACTN2-202:ENST00000546208.1:1167_1060_354_Q->*;HUB=PPI;GNEG=Yes;GENE=ACTN2;CDSS=5;DBRECUR=ACTN2:Lung_Adeno(Altered in 4/24(16.67%) samples.)
chr1	156108342	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=3.93;CDS=Yes;VA=1:LMNA:ENSG00000160789.15:+:nonsynonymous:5/10:LMNA-017:ENST00000448611.2:1725_1426_476_C->S:LMNA-006:ENST00000473598.2:1698_1465_489_C->S:LMNA-201:ENST00000347559.2:1905_1672_558_C->S:LMNA-004:ENST00000368299.3:1845_1762_588_C->S:LMNA-001:ENST00000368300.4:1995_1762_588_C->S;HUB=PPI&REG;GNEG=Yes;GENE=LMNA;CDSS=4
chr1	236881197	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=5.61;CDS=Yes;VA=1:ACTN2:ENSG00000077522.8:+:nonsynonymous:2/3:ACTN2-001:ENST00000366578.4:2685_166_56_G->C:ACTN2-201:ENST00000542672.1:2685_166_56_G->C;HUB=PPI;GNEG=Yes;GENE=ACTN2;CDSS=4;DBRECUR=ACTN2:Lung_Adeno(Altered in 4/24(16.67%) samples.)
chr10	75830528	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=5.49;CDS=Yes;VA=1:VCL:ENSG00000035403.12:+:nonsynonymous:3/3:VCL-201:ENST00000211998.4:3405_340_114_G->S:VCL-001:ENST00000372755.3:3201_340_114_G->S:VCL-202:ENST00000417648.2:984_340_114_G->S;HUB=PPI;GNEG=Yes;GENE=VCL;CDSS=4
chr10	75834647	.	T	C	.	.	SAMPLE=cardiomyopathy;GERP=5.79;CDS=Yes;VA=1:VCL:ENSG00000035403.12:+:nonsynonymous:2/3:VCL-201:ENST00000211998.4:3405_769_257_A->P:VCL-001:ENST00000372755.3:3201_769_257_A->P;HUB=PPI;GNEG=Yes;GENE=VCL;CDSS=4
chr10	75863581	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=4.98;CDS=Yes;VA=1:VCL:ENSG00000035403.12:+:nonsynonymous:2/3:VCL-201:ENST00000211998.4:3405_2026_676_V->I:VCL-001:ENST00000372755.3:3201_2026_676_V->I;HUB=PPI;GNEG=Yes;GENE=VCL;CDSS=4
chr10	88466433	.	C	A	.	.	SAMPLE=cardiomyopathy;GERP=3.23;CDS=Yes;VA=1:LDB3:ENSG00000122367.15:+:nonsynonymous:1/9:LDB3-001:ENST00000361373.4:2184_1042_348_A->T;HUB=PPI;GNEG=Yes;GENE=LDB3;CDSS=4
chr10	88466466	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=4.22;CDS=Yes;VA=1:LDB3:ENSG00000122367.15:+:nonsynonymous:1/9:LDB3-001:ENST00000361373.4:2184_1075_359_D->Y;HUB=PPI;GNEG=Yes;GENE=LDB3;CDSS=4
chr10	88478530	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=5.49;CDS=Yes;VA=1:LDB3:ENSG00000122367.15:+:nonsynonymous:5/9:LDB3-201:ENST00000263066.6:1854_1574_525_V->D:LDB3-203:ENST00000352360.5:1413_1133_378_V->D:LDB3-001:ENST00000361373.4:2184_1904_635_V->D:LDB3-205:ENST00000429277.2:2199_1919_640_V->D:LDB3-206:ENST00000458213.2:1854_1574_525_V->D;HUB=PPI;GNEG=Yes;GENE=LDB3;CDSS=4
chr11	116707756	.	C	G	.	.	SAMPLE=cardiomyopathy;GERP=3.74;CDS=Yes;VA=1:APOA1:ENSG00000118137.5:-:nonsynonymous:4/5:APOA1-001:ENST00000236850.4:804_161_54_V->A:APOA1-004:ENST00000359492.2:804_161_54_V->A:APOA1-002:ENST00000375320.1:804_161_54_V->A:APOA1-003:ENST00000375323.1:804_161_54_V->A;HUB=PPI&REG;GNEG=Yes;GENE=APOA1;CDSS=4
chr15	63354448	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=5.84;CDS=Yes;VA=1:TPM1:ENSG00000140416.15:+:nonsynonymous:12/17:TPM1-005:ENST00000267996.7:855_674_225_I->S:TPM1-008:ENST00000357980.4:981_800_267_I->S:TPM1-018:ENST00000358278.3:855_674_225_I->S:TPM1-010:ENST00000559397.1:855_674_225_I->S:TPM1-028:ENST00000559556.1:855_674_225_I->S:TPM1-002:ENST00000403994.3:855_674_225_I->S:TPM1-001:ENST00000288398.6:855_674_225_I->S:TPM1-012:ENST00000404484.4:747_566_189_I->S:TPM1-016:ENST00000317516.7:738_566_189_I->S:TPM1-011:ENST00000334895.5:738_566_189_I->S:TPM1-015:ENST00000559281.1:747_566_189_I->S:TPM1-014:ENST00000560959.1:828_566_189_I->S;HUB=PPI&REG;GNEG=Yes;GENE=TPM1;CDSS=4
chr18	32374063	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=5.43;CDS=Yes;VA=1:DTNA:ENSG00000134769.17:+:nonsynonymous:15/23:DTNA-025:ENST00000598334.1:2175_211_71_D->N:DTNA-201:ENST00000269190.7:2235_211_71_D->N:DTNA-203:ENST00000283365.9:2061_211_71_D->N:DTNA-005:ENST00000399113.3:2232_211_71_D->N:DTNA-001:ENST00000399121.5:2073_211_71_D->N:DTNA-205:ENST00000444659.1:2232_211_71_D->N:DTNA-026:ENST00000595022.1:2052_211_71_D->N:DTNA-028:ENST00000598142.1:2061_211_71_D->N:DTNA-202:ENST00000269191.6:1713_211_71_D->N:DTNA-003:ENST00000348997.5:1704_211_71_D->N:DTNA-024:ENST00000596745.1:963_211_71_D->N:DTNA-029:ENST00000597599.1:1533_211_71_D->N:DTNA-027:ENST00000598774.1:1542_211_71_D->N:DTNA-004:ENST00000315456.6:1125_211_71_D->N:DTNA-006:ENST00000554864.3:1116_211_71_D->N;HUB=PPI;GNEG=Yes;GENE=DTNA;CDSS=4;DBRECUR=DTNA:Breast(Altered in 2/119(1.68%) samples.)|Lung_Adeno(Altered in 3/24(12.50%) samples.)
chr20	30408307	.	C	G	.	.	SAMPLE=cardiomyopathy;GERP=4.7;CDS=Yes;VA=1:MYLK2:ENSG00000101306.6:+:nonsynonymous:2/2:MYLK2-001:ENST00000375985.4:1791_431_144_P->R:MYLK2-002:ENST00000375994.2:1791_431_144_P->R;HUB=PHOS;GNEG=Yes;GENE=MYLK2;CDSS=4;DBRECUR=MYLK2:Breast(Altered in 2/119(1.68%) samples.)
chr20	30412102	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=3.55;CDS=Yes;VA=1:MYLK2:ENSG00000101306.6:+:nonsynonymous:2/2:MYLK2-001:ENST00000375985.4:1791_919_307_T->S:MYLK2-002:ENST00000375994.2:1791_919_307_T->S;HUB=PHOS;GNEG=Yes;GENE=MYLK2;CDSS=4;DBRECUR=MYLK2:Breast(Altered in 2/119(1.68%) samples.)
chr7	151257696	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=5.8;CDS=Yes;VA=1:PRKAG2:ENSG00000106617.9:-:nonsynonymous:5/8:PRKAG2-001:ENST00000287878.4:1710_1592_531_R->Q:PRKAG2-003:ENST00000392801.2:1578_1460_487_R->Q:PRKAG2-201:ENST00000433631.2:1335_1217_406_R->Q:PRKAG2-004:ENST00000492843.1:1338_1220_407_R->Q:PRKAG2-002:ENST00000418337.2:987_869_290_R->Q;HUB=PPI;GNEG=Yes;GENE=PRKAG2;CDSS=4
chr7	151273525	.	G	T	.	.	SAMPLE=cardiomyopathy;GERP=5.42;CDS=Yes;VA=1:PRKAG2:ENSG00000106617.9:-:nonsynonymous:5/8:PRKAG2-001:ENST00000287878.4:1710_878_293_F->Y:PRKAG2-003:ENST00000392801.2:1578_746_249_F->Y:PRKAG2-201:ENST00000433631.2:1335_503_168_F->Y:PRKAG2-004:ENST00000492843.1:1338_506_169_F->Y:PRKAG2-002:ENST00000418337.2:987_155_52_F->Y;HUB=PPI;GNEG=Yes;GENE=PRKAG2;CDSS=4
chr1	237620035	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=4.6;CDS=Yes;VA=1:RYR2:ENSG00000198626.11:+:nonsynonymous:3/3:RYR2-001:ENST00000366574.2:14904_1612_538_A->T:RYR2-201:ENST00000360064.6:14922_1606_536_A->T:RYR2-202:ENST00000542537.1:14856_1564_522_A->T;HUB=PPI;GENE=RYR2;CDSS=3;DBRECUR=RYR2:Breast(Altered in 3/119(2.52%) samples.)|Liver(Altered in 3/88(3.41%) samples.)|Lung_Adeno(Altered in 8/24(33.33%) samples.)|Lymphoma_B(Altered in 4/24(16.67%) samples.)|Pancreas(Altered in 2/15(13.33%) samples.)
chr1	237656290	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=6.16;CDS=Yes;VA=1:RYR2:ENSG00000198626.11:+:nonsynonymous:3/3:RYR2-001:ENST00000366574.2:14904_1864_622_G->W:RYR2-201:ENST00000360064.6:14922_1858_620_G->W:RYR2-202:ENST00000542537.1:14856_1816_606_G->W;HUB=PPI;GENE=RYR2;CDSS=3;DBRECUR=RYR2:Breast(Altered in 3/119(2.52%) samples.)|Liver(Altered in 3/88(3.41%) samples.)|Lung_Adeno(Altered in 8/24(33.33%) samples.)|Lymphoma_B(Altered in 4/24(16.67%) samples.)|Pancreas(Altered in 2/15(13.33%) samples.)
chr1	237754202	.	G	C	.	.	SAMPLE=cardiomyopathy;GERP=5.22;CDS=Yes;VA=1:RYR2:ENSG00000198626.11:+:nonsynonymous:3/3:RYR2-001:ENST00000366574.2:14904_4070_1357_D->A:RYR2-201:ENST00000360064.6:14922_4064_1355_D->A:RYR2-202:ENST00000542537.1:14856_4022_1341_D->A;HUB=PPI;GENE=RYR2;CDSS=3;DBRECUR=RYR2:Breast(Altered in 3/119(2.52%) samples.)|Liver(Altered in 3/88(3.41%) samples.)|Lung_Adeno(Altered in 8/24(33.33%) samples.)|Lymphoma_B(Altered in 4/24(16.67%) samples.)|Pancreas(Altered in 2/15(13.33%) samples.)
chr1	237811767	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=5.16;CDS=Yes;VA=1:RYR2:ENSG00000198626.11:+:nonsynonymous:3/3:RYR2-001:ENST00000366574.2:14904_7366_2456_M->L:RYR2-201:ENST00000360064.6:14922_7360_2454_M->L:RYR2-202:ENST00000542537.1:14856_7318_2440_M->L;HUB=PPI;GENE=RYR2;CDSS=3;DBRECUR=RYR2:Breast(Altered in 3/119(2.52%) samples.)|Liver(Altered in 3/88(3.41%) samples.)|Lung_Adeno(Altered in 8/24(33.33%) samples.)|Lymphoma_B(Altered in 4/24(16.67%) samples.)|Pancreas(Altered in 2/15(13.33%) samples.)
chr10	88476275	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=1.25;CDS=Yes;VA=1:LDB3:ENSG00000122367.15:+:nonsynonymous:5/9:LDB3-201:ENST00000263066.6:1854_1093_365_V->M:LDB3-203:ENST00000352360.5:1413_652_218_V->M:LDB3-001:ENST00000361373.4:2184_1423_475_V->M:LDB3-205:ENST00000429277.2:2199_1438_480_V->M:LDB3-206:ENST00000458213.2:1854_1093_365_V->M;HUB=PPI;GNEG=Yes;GENE=LDB3;CDSS=3
chr11	47355476	.	G	C	.	.	SAMPLE=cardiomyopathy;GERP=3.17;CDS=Yes;VA=1:MYBPC3:ENSG00000134571.6:-:nonsynonymous:3/4:MYBPC3-201:ENST00000256993.4:3822_2988_996_F->L:MYBPC3-202:ENST00000399249.2:3825_2991_997_F->L:MYBPC3-001:ENST00000545968.1:3825_2991_997_F->L;HUB=REG;GENE=MYBPC3;CDSS=3
chr11	47359281	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=2.04;CDS=Yes;VA=1:MYBPC3:ENSG00000134571.6:-:nonsynonymous:4/4:MYBPC3-201:ENST00000256993.4:3822_2370_790_Q->H:MYBPC3-202:ENST00000399249.2:3825_2373_791_Q->H:MYBPC3-001:ENST00000545968.1:3825_2373_791_Q->H:MYBPC3-004:ENST00000544791.1:2427_2373_791_Q->H;HUB=REG;GENE=MYBPC3;CDSS=3
chr11	47364210	.	T	C	.	.	SAMPLE=cardiomyopathy;GERP=4.63;CDS=Yes;VA=1:MYBPC3:ENSG00000134571.6:-:nonsynonymous:4/4:MYBPC3-201:ENST00000256993.4:3822_1540_514_N->D:MYBPC3-202:ENST00000399249.2:3825_1543_515_N->D:MYBPC3-001:ENST00000545968.1:3825_1543_515_N->D:MYBPC3-004:ENST00000544791.1:2427_1543_515_N->D;HUB=REG;GENE=MYBPC3;CDSS=3
chr12	21971088	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=5.22;CDS=Yes;VA=1:ABCC9:ENSG00000069431.6:-:nonsynonymous:3/5:ABCC9-001:ENST00000261200.4:4650_3767_1256_L->P:ABCC9-002:ENST00000261201.4:4650_3767_1256_L->P:ABCC9-201:ENST00000345162.2:4542_3659_1220_L->P;GNEG=Yes;GENE=ABCC9;CDSS=3;DBRECUR=ABCC9:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 2/24(8.33%) samples.)|Medulloblastoma(Altered in 2/100(2.00%) samples.)|Prostate(Altered in 3/64(4.69%) samples.)
chr12	22005315	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=4.58;CDS=Yes;VA=1:ABCC9:ENSG00000069431.6:-:nonsynonymous:3/5:ABCC9-001:ENST00000261200.4:4650_2630_877_T->K:ABCC9-002:ENST00000261201.4:4650_2630_877_T->K:ABCC9-201:ENST00000345162.2:4542_2522_841_T->K;GNEG=Yes;GENE=ABCC9;CDSS=3;DBRECUR=ABCC9:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 2/24(8.33%) samples.)|Medulloblastoma(Altered in 2/100(2.00%) samples.)|Prostate(Altered in 3/64(4.69%) samples.)
chr12	22005392	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=4.58;CDS=Yes;VA=1:ABCC9:ENSG00000069431.6:-:nonsynonymous:3/5:ABCC9-001:ENST00000261200.4:4650_2553_851_M->I:ABCC9-002:ENST00000261201.4:4650_2553_851_M->I:ABCC9-201:ENST00000345162.2:4542_2445_815_M->I;GNEG=Yes;GENE=ABCC9;CDSS=3;DBRECUR=ABCC9:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 2/24(8.33%) samples.)|Medulloblastoma(Altered in 2/100(2.00%) samples.)|Prostate(Altered in 3/64(4.69%) samples.)
chr12	22068630	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=4.67;CDS=Yes;VA=1:ABCC9:ENSG00000069431.6:-:nonsynonymous:3/5:ABCC9-001:ENST00000261200.4:4650_788_263_C->F:ABCC9-002:ENST00000261201.4:4650_788_263_C->F:ABCC9-201:ENST00000345162.2:4542_788_263_C->F;GNEG=Yes;GENE=ABCC9;CDSS=3;DBRECUR=ABCC9:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 2/24(8.33%) samples.)|Medulloblastoma(Altered in 2/100(2.00%) samples.)|Prostate(Altered in 3/64(4.69%) samples.)
chr14	23857092	.	A	C	.	.	SAMPLE=cardiomyopathy;GERP=4.44;CDS=Yes;VA=1:MYH6:ENSG00000197616.7:-:nonsynonymous:2/2:MYH6-001:ENST00000356287.3:5820_4400_1467_S->C:MYH6-201:ENST00000405093.3:5820_4400_1467_S->C;GNEG=Yes;GENE=MYH6;CDSS=3;DBRECUR=MYH6:Lung_Adeno(Altered in 2/24(8.33%) samples.)|Prostate(Altered in 2/64(3.12%) samples.)
chr14	23871910	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=4.2;CDS=Yes;VA=1:MYH6:ENSG00000197616.7:-:nonsynonymous:2/2:MYH6-001:ENST00000356287.3:5820_998_333_T->I:MYH6-201:ENST00000405093.3:5820_998_333_T->I;GNEG=Yes;GENE=MYH6;CDSS=3;DBRECUR=MYH6:Lung_Adeno(Altered in 2/24(8.33%) samples.)|Prostate(Altered in 2/64(3.12%) samples.)
chr18	29172938	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=5.71;CDS=Yes;VA=1:TTR:ENSG00000118271.5:+:nonsynonymous:1/1:TTR-001:ENST00000237014.3:444_149_50_V->E;HUB=PPI&REG;GENE=TTR;CDSS=3
chr18	29175093	.	T	A	.	.	SAMPLE=cardiomyopathy;GERP=4.66;CDS=Yes;VA=1:TTR:ENSG00000118271.5:+:nonsynonymous:1/1:TTR-001:ENST00000237014.3:444_211_71_E->K;HUB=PPI&REG;GENE=TTR;CDSS=3
chr18	29175121	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=4.62;CDS=Yes;VA=1:TTR:ENSG00000118271.5:+:nonsynonymous:1/1:TTR-001:ENST00000237014.3:444_239_80_T->S;HUB=PPI&REG;GENE=TTR;CDSS=3
chr18	29178619	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=6.08;CDS=Yes;VA=1:TTR:ENSG00000118271.5:+:nonsynonymous:1/1:TTR-001:ENST00000237014.3:444_425_142_V->D;HUB=PPI&REG;GENE=TTR;CDSS=3
chr20	30409364	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=-3.91;CDS=Yes;VA=1:MYLK2:ENSG00000101306.6:+:nonsynonymous:2/2:MYLK2-001:ENST00000375985.4:1791_596_199_I->S:MYLK2-002:ENST00000375994.2:1791_596_199_I->S;HUB=PHOS;GNEG=Yes;GENE=MYLK2;CDSS=3;DBRECUR=MYLK2:Breast(Altered in 2/119(1.68%) samples.)
chr3	14180732	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=5.25;CDS=Yes;VA=1:TMEM43:ENSG00000170876.7:+:nonsynonymous:1/2:TMEM43-001:ENST00000306077.4:1203_935_312_R->L;HUB=REG;GENE=TMEM43;CDSS=3
chr3	32181724	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=5.06;CDS=Yes;VA=1:GPD1L:ENSG00000152642.6:+:nonsynonymous:1/2:GPD1L-001:ENST00000282541.5:1056_371_124_I->R,1:GPD1L:ENSG00000152642.6:+:removedStop:1/2:GPD1L-004:ENST00000428684.1:195_193_65_*->E;GNEG=Yes;GENE=GPD1L;CDSS=3
chr6	7542254	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=3.67;CDS=Yes;VA=1:DSP:ENSG00000096696.9:+:nonsynonymous:2/2:DSP-001:ENST00000379802.3:8616_106_36_G->S:DSP-002:ENST00000418664.2:6819_106_36_G->S;HUB=PPI&REG;GENE=DSP;CDSS=3;DBRECUR=DSP:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 2/24(8.33%) samples.)
chr6	7583649	.	C	G	.	.	SAMPLE=cardiomyopathy;GERP=4.98;CDS=Yes;VA=1:DSP:ENSG00000096696.9:+:nonsynonymous:2/2:DSP-001:ENST00000379802.3:8616_6154_2052_Q->E:DSP-002:ENST00000418664.2:6819_4357_1453_Q->E;HUB=PPI&REG;GENE=DSP;CDSS=3;DBRECUR=DSP:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 2/24(8.33%) samples.)
chr6	7585797	.	C	G	.	.	SAMPLE=cardiomyopathy;GERP=3.11;CDS=Yes;VA=1:DSP:ENSG00000096696.9:+:nonsynonymous:2/2:DSP-001:ENST00000379802.3:8616_8302_2768_S->G:DSP-002:ENST00000418664.2:6819_6505_2169_S->G;HUB=PPI&REG;GENE=DSP;CDSS=3;DBRECUR=DSP:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 2/24(8.33%) samples.)
chr9	108380353	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=6.02;CDS=Yes;VA=1:FKTN:ENSG00000106692.9:+:nonsynonymous:4/6:FKTN-201:ENST00000357998.5:1293_1024_342_L->I:FKTN-007:ENST00000448551.2:1293_1024_342_L->I:FKTN-001:ENST00000223528.2:1386_1024_342_L->I:FKTN-004:ENST00000602661.1:1386_1024_342_L->I;GNEG=Yes;GENE=FKTN;CDSS=3
chr9	108397457	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=2.28;CDS=Yes;VA=1:FKTN:ENSG00000106692.9:+:nonsynonymous:2/6:FKTN-001:ENST00000223528.2:1386_1298_433_T->R:FKTN-004:ENST00000602661.1:1386_1298_433_T->R;GNEG=Yes;GENE=FKTN;CDSS=3
chr9	108397496	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=4.91;CDS=Yes;VA=1:FKTN:ENSG00000106692.9:+:nonsynonymous:2/6:FKTN-001:ENST00000223528.2:1386_1337_446_N->S:FKTN-004:ENST00000602661.1:1386_1337_446_N->S;GNEG=Yes;GENE=FKTN;CDSS=3
chr1	237778085	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=-1.04;CDS=Yes;VA=1:RYR2:ENSG00000198626.11:+:nonsynonymous:3/3:RYR2-001:ENST00000366574.2:14904_5657_1886_G->D:RYR2-201:ENST00000360064.6:14922_5651_1884_G->D:RYR2-202:ENST00000542537.1:14856_5609_1870_G->D;HUB=PPI;GENE=RYR2;CDSS=2;DBRECUR=RYR2:Breast(Altered in 3/119(2.52%) samples.)|Liver(Altered in 3/88(3.41%) samples.)|Lung_Adeno(Altered in 8/24(33.33%) samples.)|Lymphoma_B(Altered in 4/24(16.67%) samples.)|Pancreas(Altered in 2/15(13.33%) samples.)
chr11	47356629	.	G	C	.	.	SAMPLE=cardiomyopathy;GERP=-0.0685;CDS=Yes;VA=1:MYBPC3:ENSG00000134571.6:-:nonsynonymous:3/4:MYBPC3-201:ENST00000256993.4:3822_2866_956_T->A:MYBPC3-202:ENST00000399249.2:3825_2869_957_T->A:MYBPC3-001:ENST00000545968.1:3825_2869_957_T->A;HUB=REG;GENE=MYBPC3;CDSS=2
chr11	47367917	.	G	T	.	.	SAMPLE=cardiomyopathy;GERP=-1.18;CDS=Yes;VA=1:MYBPC3:ENSG00000134571.6:-:nonsynonymous:4/4:MYBPC3-201:ENST00000256993.4:3822_931_311_S->T:MYBPC3-202:ENST00000399249.2:3825_931_311_S->T:MYBPC3-001:ENST00000545968.1:3825_931_311_S->T:MYBPC3-004:ENST00000544791.1:2427_931_311_S->T;HUB=REG;GENE=MYBPC3;CDSS=2
chr12	98926913	.	T	G	.	.	SAMPLE=cardiomyopathy;GERP=3.46;CDS=Yes;VA=1:TMPO:ENSG00000120802.9:+:nonsynonymous:1/5:TMPO-001:ENST00000266732.4:2085_878_293_S->W;GENE=TMPO;CDSS=2
chr14	23853709	.	T	C	.	.	SAMPLE=cardiomyopathy;GERP=-1.1;CDS=Yes;VA=1:MYH6:ENSG00000197616.7:-:nonsynonymous:2/2:MYH6-001:ENST00000356287.3:5820_5507_1836_A->G:MYH6-201:ENST00000405093.3:5820_5507_1836_A->G;GNEG=Yes;GENE=MYH6;CDSS=2;DBRECUR=MYH6:Lung_Adeno(Altered in 2/24(8.33%) samples.)|Prostate(Altered in 2/64(3.12%) samples.)
chr18	28650749	.	A	C	.	.	SAMPLE=cardiomyopathy;GERP=0.492;CDS=Yes;VA=1:DSC2:ENSG00000134755.10:-:nonsynonymous:2/2:DSC2-001:ENST00000280904.6:2706_2193_731_D->E:DSC2-002:ENST00000251081.6:2544_2193_731_D->E;GNEG=Yes;GENE=DSC2;CDSS=2
chr18	29116285	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=4.73;CDS=Yes;VA=1:DSG2:ENSG00000046604.8:+:nonsynonymous:1/2:DSG2-001:ENST00000261590.8:3357_1544_515_V->D;GENE=DSG2;CDSS=2
chr2	220283260	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=4.25;CDS=Yes;VA=1:DES:ENSG00000175084.7:+:nonsynonymous:1/1:DES-001:ENST00000373960.3:1413_76_26_L->V;GENE=DES;CDSS=2
chr2	220283278	.	T	C	.	.	SAMPLE=cardiomyopathy;GERP=5.12;CDS=Yes;VA=1:DES:ENSG00000175084.7:+:nonsynonymous:1/1:DES-001:ENST00000373960.3:1413_94_32_S->P;GENE=DES;CDSS=2
chr2	220285003	.	T	C	.	.	SAMPLE=cardiomyopathy;GERP=4.38;CDS=Yes;VA=1:DES:ENSG00000175084.7:+:nonsynonymous:1/1:DES-001:ENST00000373960.3:1413_670_224_D->H;GENE=DES;CDSS=2
chr2	73675520	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=1.27;CDS=Yes;VA=1:ALMS1:ENSG00000116127.13:+:prematureStop:3/3:ALMS1-001:ENST00000264448.6:12504_1863_621_Y->*:ALMS1-002:ENST00000409009.1:12378_1737_579_Y->*:ALMS1-201:ENST00000377715.1:7686_1863_621_Y->*;GENE=ALMS1;CDSS=2;DBRECUR=ALMS1:Lung_Adeno(Altered in 6/24(25.00%) samples.)
chr3	38592680	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=4.68;CDS=Yes;VA=1:SCN5A:ENSG00000183873.11:-:nonsynonymous:10/10:SCN5A-014:ENST00000333535.4:6051_5183_1728_C->F:SCN5A-001:ENST00000413689.1:6051_5183_1728_C->F:SCN5A-004:ENST00000414099.2:5997_5129_1710_C->F:SCN5A-003:ENST00000423572.2:6048_5180_1727_C->F:SCN5A-201:ENST00000425664.1:5997_5129_1710_C->F:SCN5A-202:ENST00000443581.1:6048_5180_1727_C->F:SCN5A-010:ENST00000449557.2:5889_5021_1674_C->F:SCN5A-008:ENST00000450102.2:5889_5021_1674_C->F:SCN5A-203:ENST00000451551.2:5889_5021_1674_C->F:SCN5A-002:ENST00000455624.2:5952_5084_1695_C->F;GENE=SCN5A;CDSS=2;DBRECUR=SCN5A:Liver(Altered in 2/88(2.27%) samples.)
chr3	38601666	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=4.3;CDS=Yes;VA=1:SCN5A:ENSG00000183873.11:-:nonsynonymous:10/10:SCN5A-014:ENST00000333535.4:6051_4217_1406_G->E:SCN5A-001:ENST00000413689.1:6051_4217_1406_G->E:SCN5A-004:ENST00000414099.2:5997_4217_1406_G->E:SCN5A-003:ENST00000423572.2:6048_4214_1405_G->E:SCN5A-201:ENST00000425664.1:5997_4217_1406_G->E:SCN5A-202:ENST00000443581.1:6048_4214_1405_G->E:SCN5A-010:ENST00000449557.2:5889_4055_1352_G->E:SCN5A-008:ENST00000450102.2:5889_4055_1352_G->E:SCN5A-203:ENST00000451551.2:5889_4055_1352_G->E:SCN5A-002:ENST00000455624.2:5952_4214_1405_G->E;GENE=SCN5A;CDSS=2;DBRECUR=SCN5A:Liver(Altered in 2/88(2.27%) samples.)
chr3	38655308	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=4.3;CDS=Yes;VA=1:SCN5A:ENSG00000183873.11:-:nonsynonymous:4/10:SCN5A-014:ENST00000333535.4:6051_629_210_V->E:SCN5A-003:ENST00000423572.2:6048_629_210_V->E:SCN5A-202:ENST00000443581.1:6048_629_210_V->E:SCN5A-010:ENST00000449557.2:5889_629_210_V->E;GENE=SCN5A;CDSS=2;DBRECUR=SCN5A:Liver(Altered in 2/88(2.27%) samples.)
chr5	155771601	.	G	C	.	.	SAMPLE=cardiomyopathy;GERP=5.59;CDS=Yes;VA=1:SGCD:ENSG00000170624.9:+:nonsynonymous:5/5:SGCD-002:ENST00000337851.4:873_106_36_Y->H:SGCD-201:ENST00000447401.1:771_106_36_Y->H:SGCD-003:ENST00000517913.1:771_106_36_Y->H:SGCD-004:ENST00000524347.1:249_106_36_Y->H:SGCD-001:ENST00000435422.3:870_103_35_Y->H;GENE=SGCD;CDSS=2;DBRECUR=SGCD:Lung_Adeno(Altered in 2/24(8.33%) samples.)
chr6	133849869	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=6.07;CDS=Yes;VA=1:EYA4:ENSG00000112319.13:+:nonsynonymous:7/8:EYA4-201:ENST00000355167.3:1920_1846_616_M->L:EYA4-008:ENST00000355286.6:1851_1777_593_M->L:EYA4-001:ENST00000367895.5:1920_1846_616_M->L:EYA4-011:ENST00000431403.2:1920_1846_616_M->L:EYA4-006:ENST00000452339.2:1758_1684_562_M->L:EYA4-002:ENST00000525849.1:1851_1777_593_M->L:EYA4-009:ENST00000531901.1:1938_1864_622_M->L;GENE=EYA4;CANG=[DNA_repair];CDSS=2
chr18	29111110	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=-0.523;CDS=Yes;VA=1:DSG2:ENSG00000046604.8:+:nonsynonymous:1/2:DSG2-001:ENST00000261590.8:3357_1175_392_V->D;GENE=DSG2;CDSS=1
chr2	73676413	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=1.94;CDS=Yes;VA=1:ALMS1:ENSG00000116127.13:+:nonsynonymous:3/3:ALMS1-001:ENST00000264448.6:12504_2756_919_Q->L:ALMS1-002:ENST00000409009.1:12378_2630_877_Q->L:ALMS1-201:ENST00000377715.1:7686_2756_919_Q->L;GENE=ALMS1;CDSS=1;DBRECUR=ALMS1:Lung_Adeno(Altered in 6/24(25.00%) samples.)
chr1	201333495	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=-3.62;CDS=Yes;VA=1:TNNT2:ENSG00000118194.14:-:synonymous:10/10:TNNT2-201:ENST00000236918.7:882_405_135_R->R:TNNT2-202:ENST00000360372.4:852_375_125_R->R:TNNT2-203:ENST00000367315.2:858_390_130_R->R:TNNT2-204:ENST00000367317.4:867_390_130_R->R:TNNT2-005:ENST00000367318.5:867_390_130_R->R:TNNT2-003:ENST00000367320.2:768_300_100_R->R:TNNT2-001:ENST00000367322.1:858_390_130_R->R:TNNT2-205:ENST00000421663.2:876_396_132_R->R:TNNT2-206:ENST00000458432.2:894_426_142_R->R:TNNT2-008:ENST00000509001.1:867_390_130_R->R;GENE=TNNT2;CDSS=0
chr1	236918484	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=4.62;CDS=Yes;VA=1:ACTN2:ENSG00000077522.8:+:synonymous:3/3:ACTN2-001:ENST00000366578.4:2685_2140_714_N->N:ACTN2-201:ENST00000542672.1:2685_2140_714_N->N:ACTN2-202:ENST00000546208.1:1167_622_208_N->N;GENE=ACTN2;CDSS=0;DBRECUR=ACTN2:Lung_Adeno(Altered in 4/24(16.67%) samples.)
chr1	236918492	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=-0.775;CDS=Yes;VA=1:ACTN2:ENSG00000077522.8:+:synonymous:3/3:ACTN2-001:ENST00000366578.4:2685_2148_716_T->T:ACTN2-201:ENST00000542672.1:2685_2148_716_T->T:ACTN2-202:ENST00000546208.1:1167_630_210_T->T;GENE=ACTN2;CDSS=0;DBRECUR=ACTN2:Lung_Adeno(Altered in 4/24(16.67%) samples.)
chr1	237841391	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=4.55;CDS=Yes;VA=1:RYR2:ENSG00000198626.11:+:synonymous:3/3:RYR2-001:ENST00000366574.2:14904_8874_2958_Q->Q:RYR2-201:ENST00000360064.6:14922_8868_2956_Q->Q:RYR2-202:ENST00000542537.1:14856_8826_2942_Q->Q;GENE=RYR2;CDSS=0;DBRECUR=RYR2:Breast(Altered in 3/119(2.52%) samples.)|Liver(Altered in 3/88(3.41%) samples.)|Lung_Adeno(Altered in 8/24(33.33%) samples.)|Lymphoma_B(Altered in 4/24(16.67%) samples.)|Pancreas(Altered in 2/15(13.33%) samples.)
chr1	237875069	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=4.97;CDS=Yes;VA=1:RYR2:ENSG00000198626.11:+:synonymous:3/3:RYR2-001:ENST00000366574.2:14904_10255_3419_F->F:RYR2-201:ENST00000360064.6:14922_10249_3417_F->F:RYR2-202:ENST00000542537.1:14856_10207_3403_F->F;GENE=RYR2;CDSS=0;DBRECUR=RYR2:Breast(Altered in 3/119(2.52%) samples.)|Liver(Altered in 3/88(3.41%) samples.)|Lung_Adeno(Altered in 8/24(33.33%) samples.)|Lymphoma_B(Altered in 4/24(16.67%) samples.)|Pancreas(Altered in 2/15(13.33%) samples.)
chr1	237961410	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=5.57;CDS=Yes;VA=1:RYR2:ENSG00000198626.11:+:synonymous:3/3:RYR2-001:ENST00000366574.2:14904_14030_4677_L->L:RYR2-201:ENST00000360064.6:14922_14048_4683_L->L:RYR2-202:ENST00000542537.1:14856_13982_4661_L->L;GENE=RYR2;CDSS=0;DBRECUR=RYR2:Breast(Altered in 3/119(2.52%) samples.)|Liver(Altered in 3/88(3.41%) samples.)|Lung_Adeno(Altered in 8/24(33.33%) samples.)|Lymphoma_B(Altered in 4/24(16.67%) samples.)|Pancreas(Altered in 2/15(13.33%) samples.)
chr10	88439896	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=-10.6;CDS=Yes;VA=1:LDB3:ENSG00000122367.15:+:synonymous:9/9:LDB3-201:ENST00000263066.6:1854_303_101_P->P:LDB3-203:ENST00000352360.5:1413_303_101_P->P:LDB3-001:ENST00000361373.4:2184_303_101_P->P:LDB3-205:ENST00000429277.2:2199_303_101_P->P:LDB3-206:ENST00000458213.2:1854_303_101_P->P:LDB3-202:ENST00000310944.6:993_303_101_P->P:LDB3-204:ENST00000372056.4:1197_303_101_P->P:LDB3-002:ENST00000372066.3:852_303_101_P->P:LDB3-207:ENST00000542786.1:696_303_101_P->P;GENE=LDB3;CDSS=0
chr10	88451716	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=2.09;CDS=Yes;VA=1:LDB3:ENSG00000122367.15:+:synonymous:7/9:LDB3-201:ENST00000263066.6:1854_612_204_K->K:LDB3-001:ENST00000361373.4:2184_753_251_K->K:LDB3-205:ENST00000429277.2:2199_957_319_K->K:LDB3-206:ENST00000458213.2:1854_612_204_K->K:LDB3-202:ENST00000310944.6:993_753_251_K->K:LDB3-204:ENST00000372056.4:1197_957_319_K->K:LDB3-002:ENST00000372066.3:852_612_204_K->K;GENE=LDB3;CDSS=0
chr11	19207813	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=4.91;CDS=Yes;VA=1:CSRP3:ENSG00000129170.4:-:synonymous:2/2:CSRP3-201:ENST00000265968.3:585_364_122_R->R:CSRP3-002:ENST00000533783.1:585_364_122_R->R;GENE=CSRP3;CDSS=0
chr11	47355554	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=-10.2;CDS=Yes;VA=1:MYBPC3:ENSG00000134571.6:-:synonymous:3/4:MYBPC3-201:ENST00000256993.4:3822_2910_970_P->P:MYBPC3-202:ENST00000399249.2:3825_2913_971_P->P:MYBPC3-001:ENST00000545968.1:3825_2913_971_P->P;GENE=MYBPC3;CDSS=0
chr11	47360072	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=2.52;CDS=Yes;VA=1:MYBPC3:ENSG00000134571.6:-:synonymous:4/4:MYBPC3-201:ENST00000256993.4:3822_2304_768_I->I:MYBPC3-202:ENST00000399249.2:3825_2307_769_I->I:MYBPC3-001:ENST00000545968.1:3825_2307_769_I->I:MYBPC3-004:ENST00000544791.1:2427_2307_769_I->I;GENE=MYBPC3;CDSS=0
chr11	47362724	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=4.72;CDS=Yes;VA=1:MYBPC3:ENSG00000134571.6:-:synonymous:4/4:MYBPC3-201:ENST00000256993.4:3822_1859_620_F->F:MYBPC3-202:ENST00000399249.2:3825_1862_621_F->F:MYBPC3-001:ENST00000545968.1:3825_1862_621_F->F:MYBPC3-004:ENST00000544791.1:2427_1862_621_F->F;GENE=MYBPC3;CDSS=0
chr11	47364603	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=-9.45;CDS=Yes;VA=1:MYBPC3:ENSG00000134571.6:-:synonymous:4/4:MYBPC3-201:ENST00000256993.4:3822_1317_439_G->G:MYBPC3-202:ENST00000399249.2:3825_1320_440_G->G:MYBPC3-001:ENST00000545968.1:3825_1320_440_G->G:MYBPC3-004:ENST00000544791.1:2427_1320_440_G->G;GENE=MYBPC3;CDSS=0
chr11	47371451	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=3.88;CDS=Yes;VA=1:MYBPC3:ENSG00000134571.6:-:synonymous:4/4:MYBPC3-201:ENST00000256993.4:3822_528_176_A->A:MYBPC3-202:ENST00000399249.2:3825_528_176_A->A:MYBPC3-001:ENST00000545968.1:3825_528_176_A->A:MYBPC3-004:ENST00000544791.1:2427_528_176_A->A;GENE=MYBPC3;CDSS=0
chr12	21995401	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=5.31;CDS=Yes;VA=1:ABCC9:ENSG00000069431.6:-:synonymous:3/5:ABCC9-001:ENST00000261200.4:4650_3320_1107_I->I:ABCC9-002:ENST00000261201.4:4650_3320_1107_I->I:ABCC9-201:ENST00000345162.2:4542_3212_1071_I->I;GENE=ABCC9;CDSS=0;DBRECUR=ABCC9:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 2/24(8.33%) samples.)|Medulloblastoma(Altered in 2/100(2.00%) samples.)|Prostate(Altered in 3/64(4.69%) samples.)
chr12	32977027	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=4.56;CDS=Yes;VA=1:PKP2:ENSG00000057294.9:-:synonymous:2/2:PKP2-002:ENST00000070846.6:2646_1758_586_L->L:PKP2-001:ENST00000340811.4:2514_1626_542_L->L;GENE=PKP2;CDSS=0
chr12	98926749	.	T	G	.	.	SAMPLE=cardiomyopathy;GERP=1.37;CDS=Yes;VA=1:TMPO:ENSG00000120802.9:+:synonymous:1/5:TMPO-001:ENST00000266732.4:2085_714_238_L->L;GENE=TMPO;CDSS=0
chr12	98926986	.	C	G	.	.	SAMPLE=cardiomyopathy;GERP=4.64;CDS=Yes;VA=1:TMPO:ENSG00000120802.9:+:synonymous:1/5:TMPO-001:ENST00000266732.4:2085_951_317_T->T;GENE=TMPO;CDSS=0
chr12	98927470	.	G	C	.	.	SAMPLE=cardiomyopathy;GERP=-0.433;CDS=Yes;VA=1:TMPO:ENSG00000120802.9:+:synonymous:1/5:TMPO-001:ENST00000266732.4:2085_1435_479_Q->Q;GENE=TMPO;CDSS=0
chr14	23868076	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=-7;CDS=Yes;VA=1:MYH6:ENSG00000197616.7:-:synonymous:2/2:MYH6-001:ENST00000356287.3:5820_1752_584_A->A:MYH6-201:ENST00000405093.3:5820_1752_584_A->A;GENE=MYH6;CDSS=0;DBRECUR=MYH6:Lung_Adeno(Altered in 2/24(8.33%) samples.)|Prostate(Altered in 2/64(3.12%) samples.)
chr14	23884861	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=4.51;CDS=Yes;VA=1:MYH7:ENSG00000092054.12:-:synonymous:1/1:MYH7-001:ENST00000355349.3:5808_5134_1712_R->R;GENE=MYH7;CDSS=0;DBRECUR=MYH7:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 4/24(16.67%) samples.)
chr14	23887608	.	G	T	.	.	SAMPLE=cardiomyopathy;GERP=4.97;CDS=Yes;VA=1:MYH7:ENSG00000092054.12:-:synonymous:1/1:MYH7-001:ENST00000355349.3:5808_3980_1327_N->N;GENE=MYH7;CDSS=0;DBRECUR=MYH7:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 4/24(16.67%) samples.)
chr14	23888765	.	T	G	.	.	SAMPLE=cardiomyopathy;GERP=-7.69;CDS=Yes;VA=1:MYH7:ENSG00000092054.12:-:synonymous:1/1:MYH7-001:ENST00000355349.3:5808_3780_1260_R->R;GENE=MYH7;CDSS=0;DBRECUR=MYH7:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 4/24(16.67%) samples.)
chr15	35085600	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=-11.3;CDS=Yes;VA=1:ACTC1:ENSG00000159251.6:-:synonymous:1/1:ACTC1-001:ENST00000290378.4:1134_300_100_P->P;GENE=ACTC1;CDSS=0
chr15	63353099	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=5.8;CDS=Yes;VA=1:TPM1:ENSG00000140416.15:+:synonymous:14/17:TPM1-005:ENST00000267996.7:855_524_175_D->D:TPM1-008:ENST00000357980.4:981_650_217_D->D:TPM1-018:ENST00000358278.3:855_524_175_D->D:TPM1-010:ENST00000559397.1:855_524_175_D->D:TPM1-028:ENST00000559556.1:855_524_175_D->D:TPM1-002:ENST00000403994.3:855_524_175_D->D:TPM1-001:ENST00000288398.6:855_524_175_D->D:TPM1-009:ENST00000558347.1:474_406_136_T->T:TPM1-012:ENST00000404484.4:747_416_139_D->D:TPM1-016:ENST00000317516.7:738_416_139_D->D:TPM1-011:ENST00000334895.5:738_416_139_D->D:TPM1-015:ENST00000559281.1:747_416_139_D->D:TPM1-014:ENST00000560959.1:828_416_139_D->D:TPM1-017:ENST00000558264.1:279_146_49_D->D;GENE=TPM1;CDSS=0
chr18	28660233	.	T	C	.	.	SAMPLE=cardiomyopathy;GERP=-2.07;CDS=Yes;VA=1:DSC2:ENSG00000134755.10:-:synonymous:2/2:DSC2-001:ENST00000280904.6:2706_1349_450_R->R:DSC2-002:ENST00000251081.6:2544_1349_450_R->R;GENE=DSC2;CDSS=0
chr18	28666647	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=-9.66;CDS=Yes;VA=1:DSC2:ENSG00000134755.10:-:synonymous:2/2:DSC2-001:ENST00000280904.6:2706_834_278_T->T:DSC2-002:ENST00000251081.6:2544_834_278_T->T;GENE=DSC2;CDSS=0
chr18	29104715	.	A	T	.	.	SAMPLE=cardiomyopathy;GERP=5.35;CDS=Yes;VA=1:DSG2:ENSG00000046604.8:+:synonymous:1/2:DSG2-001:ENST00000261590.8:3357_878_293_I->I;GENE=DSG2;CDSS=0
chr18	29125997	.	T	C	.	.	SAMPLE=cardiomyopathy;GERP=2.68;CDS=Yes;VA=1:DSG2:ENSG00000046604.8:+:synonymous:1/2:DSG2-001:ENST00000261590.8:3357_2648_883_S->S;GENE=DSG2;CDSS=0
chr18	29126058	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=-0.21;CDS=Yes;VA=1:DSG2:ENSG00000046604.8:+:synonymous:1/2:DSG2-001:ENST00000261590.8:3357_2709_903_T->T;GENE=DSG2;CDSS=0
chr19	55663274	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=1.07;CDS=Yes;VA=1:TNNI3:ENSG00000129991.8:-:synonymous:2/2:TNNI3-001:ENST00000344887.5:633_561_187_E->E:TNNI3-006:ENST00000588882.1:558_486_162_E->E;GENE=TNNI3;CDSS=0
chr20	30419814	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=3.76;CDS=Yes;VA=1:MYLK2:ENSG00000101306.6:+:synonymous:2/2:MYLK2-001:ENST00000375985.4:1791_1585_529_M->M:MYLK2-002:ENST00000375994.2:1791_1585_529_M->M;GENE=MYLK2;CDSS=0;DBRECUR=MYLK2:Breast(Altered in 2/119(1.68%) samples.)
chr3	38655291	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=4.3;CDS=Yes;VA=1:SCN5A:ENSG00000183873.11:-:synonymous:4/10:SCN5A-014:ENST00000333535.4:6051_646_216_S->S:SCN5A-003:ENST00000423572.2:6048_646_216_S->S:SCN5A-202:ENST00000443581.1:6048_646_216_S->S:SCN5A-010:ENST00000449557.2:5889_646_216_S->S;GENE=SCN5A;CDSS=0;DBRECUR=SCN5A:Liver(Altered in 2/88(2.27%) samples.)
chr3	46899904	.	T	C	.	.	SAMPLE=cardiomyopathy;GERP=3.77;CDS=Yes;VA=1:MYL3:ENSG00000160808.5:-:synonymous:2/2:MYL3-001:ENST00000292327.4:588_529_177_E->E:MYL3-002:ENST00000395869.1:588_529_177_E->E;GENE=MYL3;CDSS=0
chr3	8787515	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=4.93;CDS=Yes;VA=1:CAV3:ENSG00000182533.6:+:synonymous:2/2:CAV3-001:ENST00000343849.2:456_418_140_C->C:CAV3-002:ENST00000397368.2:456_418_140_C->C;GENE=CAV3;CDSS=0
chr6	7565728	.	A	T	.	.	SAMPLE=cardiomyopathy;GERP=5.55;CDS=Yes;VA=1:DSP:ENSG00000096696.9:+:synonymous:2/2:DSP-001:ENST00000379802.3:8616_914_305_I->I:DSP-002:ENST00000418664.2:6819_914_305_I->I;GENE=DSP;CDSS=0;DBRECUR=DSP:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 2/24(8.33%) samples.)
chr6	7581197	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=4.72;CDS=Yes;VA=1:DSP:ENSG00000096696.9:+:synonymous:1/2:DSP-001:ENST00000379802.3:8616_4774_1592_K->K;GENE=DSP;CDSS=0;DBRECUR=DSP:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 2/24(8.33%) samples.)
chr6	7585460	.	C	G	.	.	SAMPLE=cardiomyopathy;GERP=4.01;CDS=Yes;VA=1:DSP:ENSG00000096696.9:+:synonymous:2/2:DSP-001:ENST00000379802.3:8616_7965_2655_A->A:DSP-002:ENST00000418664.2:6819_6168_2056_A->A;GENE=DSP;CDSS=0;DBRECUR=DSP:Liver(Altered in 2/88(2.27%) samples.)|Lung_Adeno(Altered in 2/24(8.33%) samples.)
chr7	151478407	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=-4.93;CDS=Yes;VA=1:PRKAG2:ENSG00000106617.9:-:synonymous:3/8:PRKAG2-001:ENST00000287878.4:1710_297_99_P->P:PRKAG2-003:ENST00000392801.2:1578_165_55_P->P:PRKAG2-006:ENST00000488258.1:690_297_99_P->P;GENE=PRKAG2;CDSS=0
chr1	237664005	.	C	G	.	.	SAMPLE=cardiomyopathy;GERP=2.8;CDS=No;HUB=RYR2:PPI(0.804);NCENC=TFM(JUN,JUND|E2F7_1|chr1:237663995-237664009),TFM(JUN,JUND|E2F8_1|chr1:237663996-237664008),TFP(JUND|chr1:237663884-237664241);MOTIFBR=JUN,JUND#E2F7_1#237663995#237664009#+#10#0.017085#0.981910,JUN,JUND#E2F8_1#237663996#237664008#+#9#0.040404#0.939394;GENE=RYR2(Intron);NCDS=2.1456056161159
chr3	38618143	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=3.29;CDS=No;HUB=SCN5A:PPI(0.657);NCENC=DHS(MCV-2|chr3:38618085-38618235),TFM(DHS|HIC1_2|chr3:38618130-38618148);MOTIFBR=DHS#HIC1_2#38618130#38618148#+#13#0.190000#0.280000;GENE=SCN5A(Intron);NCDS=1.92817934602118
chr18	32455371	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=0.918;CDS=No;HUB=DTNA:PPI(0.846);NCENC=Enhancer(Roadmap_stringent|chr18:32455237-32455581);MOTIFG=ZNF354C_1#32455366#32455372#-#2#6.856#5.228;GENE=DTNA(Intron&Promoter);NCDS=1.76293169386166
chr1	156100389	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=1.76;CDS=No;HUB=LMNA:PHOS(0.276)PPI(0.910)REG(0.963);NCENC=Enhancer(Roadmap_stringent|chr1:156098261-156100562),TFP(CTCF|chr1:156099966-156100611),TFP(CTCF|chr1:156099998-156100617),TFP(CTCF|chr1:156100000-156100635),TFP(CTCF|chr1:156100027-156100560),TFP(CTCF|chr1:156100035-156100477),TFP(CTCF|chr1:156100040-156100622),TFP(CTCF|chr1:156100053-156100638),TFP(CTCF|chr1:156100060-156100500),TFP(CTCF|chr1:156100069-156100532),TFP(CTCF|chr1:156100071-156100589),TFP(CTCF|chr1:156100072-156100524),TFP(CTCF|chr1:156100073-156100515),TFP(CTCF|chr1:156100073-156100516),TFP(CTCF|chr1:156100073-156100612),TFP(CTCF|chr1:156100075-156100482),TFP(CTCF|chr1:156100075-156100512),TFP(CTCF|chr1:156100075-156100671),TFP(CTCF|chr1:156100076-156100483),TFP(CTCF|chr1:156100076-156100605),TFP(CTCF|chr1:156100077-156100662),TFP(CTCF|chr1:156100078-156100510),TFP(CTCF|chr1:156100079-156100496),TFP(CTCF|chr1:156100081-156100488),TFP(CTCF|chr1:156100083-156100499),TFP(CTCF|chr1:156100084-156100534),TFP(CTCF|chr1:156100085-156100521),TFP(CTCF|chr1:156100086-156100609),TFP(CTCF|chr1:156100087-156100608),TFP(CTCF|chr1:156100088-156100646),TFP(CTCF|chr1:156100090-156100544),TFP(CTCF|chr1:156100091-156100508),TFP(CTCF|chr1:156100092-156100509),TFP(CTCF|chr1:156100092-156100633),TFP(CTCF|chr1:156100093-156100625),TFP(CTCF|chr1:156100093-156100689),TFP(CTCF|chr1:156100094-156100509),TFP(CTCF|chr1:156100094-156100511),TFP(CTCF|chr1:156100094-156100629),TFP(CTCF|chr1:156100094-156100633),TFP(CTCF|chr1:156100095-156100510),TFP(CTCF|chr1:156100095-156100517),TFP(CTCF|chr1:156100095-156100548),TFP(CTCF|chr1:156100095-156100561),TFP(CTCF|chr1:156100096-156100484),TFP(CTCF|chr1:156100096-156100501),TFP(CTCF|chr1:156100096-156100509),TFP(CTCF|chr1:156100096-156100514),TFP(CTCF|chr1:156100097-156100549),TFP(CTCF|chr1:156100099-156100549),TFP(CTCF|chr1:156100102-156100593),TFP(CTCF|chr1:156100103-156100495),TFP(CTCF|chr1:156100103-156100635),TFP(CTCF|chr1:156100105-156100510),TFP(CTCF|chr1:156100106-156100551),TFP(CTCF|chr1:156100106-156100564),TFP(CTCF|chr1:156100106-156100580),TFP(CTCF|chr1:156100107-156100661),TFP(CTCF|chr1:156100108-156100491),TFP(CTCF|chr1:156100108-156100534),TFP(CTCF|chr1:156100109-156100528),TFP(CTCF|chr1:156100110-156100524),TFP(CTCF|chr1:156100110-156100638),TFP(CTCF|chr1:156100111-156100523),TFP(CTCF|chr1:156100111-156100546),TFP(CTCF|chr1:156100112-156100495),TFP(CTCF|chr1:156100114-156100502),TFP(CTCF|chr1:156100114-156100545),TFP(CTCF|chr1:156100138-156100484),TFP(ELF1|chr1:156099884-156100391),TFP(EP300|chr1:156099687-156100459),TFP(EP300|chr1:156099812-156100427),TFP(FOSL1|chr1:156099975-156100398),TFP(FOSL2|chr1:156099906-156100449),TFP(FOS|chr1:156099883-156100598),TFP(FOS|chr1:156099888-156100463),TFP(FOS|chr1:156099926-156100403),TFP(JUNB|chr1:156099905-156100489),TFP(JUND|chr1:156099767-156100421),TFP(JUND|chr1:156099782-156100433),TFP(JUND|chr1:156099803-156100487),TFP(JUND|chr1:156099838-156100426),TFP(JUND|chr1:156099872-156100436),TFP(JUN|chr1:156099980-156100405),TFP(MAX|chr1:156099801-156100416),TFP(MAX|chr1:156099958-156100418),TFP(MYC|chr1:156099765-156100692),TFP(MYC|chr1:156099813-156100456),TFP(MYC|chr1:156099884-156100392),TFP(NFKB1|chr1:156100020-156100433),TFP(RAD21|chr1:156099772-156100524),TFP(RAD21|chr1:156099779-156100516),TFP(RAD21|chr1:156099825-156100506),TFP(RAD21|chr1:156099875-156100497),TFP(RAD21|chr1:156099897-156100508),TFP(RAD21|chr1:156099903-156100511),TFP(RAD21|chr1:156099955-156100504),TFP(RAD21|chr1:156099982-156100503),TFP(RAD21|chr1:156100025-156100495),TFP(RAD21|chr1:156100054-156100464),TFP(RXRA|chr1:156099857-156100403),TFP(SMARCB1|chr1:156099720-156100591),TFP(SMARCC1|chr1:156099649-156100476),TFP(SMARCC2|chr1:156099685-156100396),TFP(SMC3|chr1:156099669-156100535),TFP(SMC3|chr1:156099901-156100547),TFP(SMC3|chr1:156099920-156100578),TFP(TFAP2A|chr1:156099752-156100455),TFP(TFAP2C|chr1:156099658-156100471),TFP(TRIM28|chr1:156099847-156100435),TFP(YY1|chr1:156100143-156100461),TFP(ZBTB7A|chr1:156100043-156100424),TFP(ZNF143|chr1:156100118-156100452),TFP(ZNF263|chr1:156099974-156100431);HOT=Gm12878,H1hesc,Helas3,Hepg2;GENE=LMNA(Intron);NCDS=1.70282713638953
chr20	30412170	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=0.456;CDS=No;HUB=MYLK2:PHOS(0.893)PPI(0.729);NCENC=DHS(MCV-1|chr20:30412120-30412270),Enhancer(chmm/segway|chr20:30411400-30412760),TFM(DHS|EGR1_disc1|chr20:30412166-30412176),TFM(DHS|EGR1_known11|chr20:30412163-30412178),TFM(DHS|EGR1_known12|chr20:30412162-30412178),TFM(DHS|EGR1_known1|chr20:30412164-30412176),TFM(DHS|EGR1_known5|chr20:30412165-30412176),TFM(DHS|EGR1_known6|chr20:30412159-30412182),TFM(DHS|EGR1_known7|chr20:30412163-30412177),TFM(DHS|EGR1_known8|chr20:30412163-30412177),TFM(DHS|EGR1_known9|chr20:30412163-30412177),TFM(DHS|EGR3_2|chr20:30412163-30412178),TFM(DHS|EGR3_3|chr20:30412162-30412177),TFM(DHS|EGR4_1|chr20:30412164-30412176),TFM(DHS|ZIC2_1|chr20:30412169-30412178);MOTIFBR=DHS#EGR1_known6#30412159#30412182#-#13#0.007366#0.355443,DHS#EGR3_3#30412162#30412177#-#8#0.001741#0.203134,DHS#EGR1_known12#30412162#30412178#-#9#0.000000#0.481306,DHS#EGR1_known7#30412163#30412177#-#8#0.003187#0.731732,DHS#EGR1_known8#30412163#30412177#-#8#0.003769#0.343593,DHS#EGR1_known9#30412163#30412177#-#8#0.000000#0.200000,DHS#EGR1_known11#30412163#30412178#-#9#0.003629#0.112903,DHS#EGR3_2#30412163#30412178#-#9#0.002455#0.279312,DHS#EGR1_known1#30412164#30412176#+#6#0.000000#0.145145,DHS#EGR4_1#30412164#30412176#+#6#0.000000#0.093000,DHS#EGR1_known5#30412165#30412176#+#5#0.000000#0.200000,DHS#EGR1_disc1#30412166#30412176#-#7#0.000000#0.638889,DHS#ZIC2_1#30412169#30412178#+#1#0.200000#0.433333;GENE=MYLK2(Intron);NCDS=1.69569063918319
chr10	88451650	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=4.93;CDS=No;HUB=LDB3:PHOS(0.276)PPI(0.897);NCENC=Enhancer(Roadmap_stringent|chr10:88448802-88451929);GENE=LDB3(Distal&Intron);NCDS=1.5262069552461
chr6	7571599	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=2.65;CDS=No;HUB=DSP:PPI(0.853)REG(0.830);GENE=DSP(Intron);NCDS=1.24576043315705
chr3	14172309	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=3.37;CDS=No;HUB=TMEM43:PPI(0.142)REG(0.830);GENE=TMEM43(Intron);NCDS=1.20111711753833
chr1	237995838	.	C	G	.	.	SAMPLE=cardiomyopathy;GERP=3.23;CDS=No;HUB=RYR2:PPI(0.804);GENE=RYR2(Intron);NCDS=1.1544909263659
chr14	23889444	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=5.13;CDS=No;HUB=MYH7:PPI(0.657)REG(0.409);NCENC=DHS(MCV-13|chr14:23889345-23889495),Enhancer(Roadmap_stringent|chr14:23889423-23890621);GENE=MYH6(Distal)MYH7(Intron);NCDS=1.13857696602118
chr3	38628880	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=4.29;CDS=No;HUB=SCN5A:PPI(0.657);NCENC=DHS(MCV-3|chr3:38628865-38629015);GENE=SCN5A(Intron);NCDS=1.13857696602118
chr1	156104780	.	G	T	.	.	SAMPLE=cardiomyopathy;GERP=0.293;CDS=No;HUB=LMNA:PHOS(0.276)PPI(0.910)REG(0.963),RAB25:PPI(0.685);NCENC=Enhancer(Roadmap_stringent|chr1:156103946-156105895);GENE=C1orf85(Distal)LMNA(Intron&Promoter)RAB25(Distal);NCDS=1.07424725225322
chr1	201328747	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=2.91;CDS=No;HUB=TNNT2:PPI(0.448)REG(0.409);NCENC=DHS(MCV-9|chr1:201328720-201328870);GENE=TNNT2(Intron);NCDS=0.976198634406367
chr14	23855358	.	T	A	.	.	SAMPLE=cardiomyopathy;GERP=1.22;CDS=No;NCENC=DHS(MCV-2|chr14:23855325-23855475),Enhancer(chmm/segway|chr14:23854965-23855941);HOT=Hepg2;GENE=MYH6(Intron);NCDS=0.800092844007081
chr20	30414529	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=0.359;CDS=No;HUB=MYLK2:PHOS(0.893)PPI(0.729);GENE=MYLK2(Intron&Promoter);NCDS=0.708977845833191
chr20	30419955	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=-1.9;CDS=No;HUB=MYLK2:PHOS(0.893)PPI(0.729);GENE=MYLK2(Intron);NCDS=0.708977845833191
chr18	29178514	.	G	C	.	.	SAMPLE=cardiomyopathy;GERP=-1.1;CDS=No;HUB=TTR:PPI(0.887)REG(0.830);GENE=TTR(Intron);NCDS=0.695357623203831
chr9	108363421	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=5.65;CDS=No;GENE=FKTN(Intron);NCDS=0.625649643
chr9	108363423	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=4.75;CDS=No;GENE=FKTN(Intron);NCDS=0.625649643
chr6	7571825	.	T	C	.	.	SAMPLE=cardiomyopathy;GERP=0.838;CDS=No;HUB=DSP:PPI(0.853)REG(0.830);GENE=DSP(Intron);NCDS=0.622973685157059
chr18	32459698	.	G	A	.	.	SAMPLE=cardiomyopathy;GERP=0.916;CDS=No;HUB=DTNA:PPI(0.846);GENE=DTNA(Intron);NCDS=0.609033502786301
chr1	237538106	.	T	C	.	.	SAMPLE=cardiomyopathy;GERP=-6.84;CDS=No;HUB=RYR2:PPI(0.804);GENE=RYR2(Intron);NCDS=0.531704178365898
chr1	237948287	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=-5.82;CDS=No;HUB=RYR2:PPI(0.804);GENE=RYR2(Intron);NCDS=0.531704178365898
chr12	22005168	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=-3.79;CDS=No;HUB=ABCC9:PPI(0.671);NCENC=TFP(STAT3|chr12:22004999-22005551),TFP(STAT3|chr12:22005020-22005600),TFP(STAT3|chr12:22005042-22005514);GENE=ABCC9(Intron);NCDS=0.531096528412772
chr19	55665585	.	A	C	.	.	SAMPLE=cardiomyopathy;GERP=-0.24;CDS=No;HUB=TNNI3:PPI(0.685)REG(0.409);GENE=TNNI3(Intron&Promoter);NCDS=0.361897230901056
chr12	22089620	.	A	G	.	.	SAMPLE=cardiomyopathy;GERP=1.5;CDS=No;HUB=ABCC9:PPI(0.671);GENE=ABCC9(Promoter&UTR);NCDS=0.345882726277408
chr12	33031838	.	A	C	.	.	SAMPLE=cardiomyopathy;GERP=-0.0747;CDS=No;HUB=PKP2:PPI(0.657);GENE=PKP2(Intron);NCDS=0.330575898021183
chr5	155935721	.	T	C	.	.	SAMPLE=cardiomyopathy;GERP=-1.32;CDS=No;HUB=SGCD:PPI(0.623);GENE=SGCD(Intron);NCDS=0.296164273666117
chr14	23855845	.	T	G	.	.	SAMPLE=cardiomyopathy;GERP=1.54;CDS=No;NCENC=Enhancer(chmm/segway|chr14:23854965-23855941),TFM(DHS|SP1_disc3|chr14:23855834-23855849),TFM(DHS|STAT_disc7|chr14:23855834-23855847);GENE=MYH6(Intron);NCDS=0.188079779991903
chr14	23855512	.	C	T	.	.	SAMPLE=cardiomyopathy;GERP=-7.42;CDS=No;NCENC=DHS(MCV-2|chr14:23855505-23855655),Enhancer(chmm/segway|chr14:23854965-23855941),TFM(DHS|E2F_disc3|chr14:23855504-23855517),TFM(DHS|NFKB_known4|chr14:23855499-23855513),TFM(DHS|SP1_disc3|chr14:23855506-23855521),TFM(DHS|SP1_known2|chr14:23855505-23855518),TFM(DHS|SP1_known6|chr14:23855507-23855517),TFM(DHS|SP4_1|chr14:23855505-23855522);GENE=MYH6(Intron);NCDS=0.188077215
chr18	28666527	.	T	A	.	.	SAMPLE=cardiomyopathy;GERP=-4.51;CDS=No;HUB=DSC2:PPI(0.408);GENE=DSC2(Intron);NCDS=0.147793980297766
